Organogenesis (ORGO) Reports Q2 Loss, Tops Revenue Estimates

Organogenesis (ORGO) came out with a quarterly loss of $0.13 per share versus the Zacks Consensus Estimate of a loss of$ 0.02. This compares to earnings of $0.04 per share a year ago. These figures are adjusted for nonrecurring items. This quarterly report represents an earnings surprise of -550%. A quarter ago, it was expected that this regenerative medicine company would post a loss of$ 0.03 per share when it actually produced a loss of $0.02, delivering a surprise of 33.33%. Over the last four quarters, ...